Drugs for Keratosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 158)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Hydrogen peroxide |
Approved, Vet_approved |
Phase 4 |
|
7722-84-1 |
784 |
Synonyms:
[OH(OH)]
A-101
Adeka super el
Albone
Albone 35
Albone DS
Anti-keim 50
Asepticper
Baquashock
CIX
Clarigel gold
Crestal whitestrips
Crystacide
Dentasept
Deslime LP
Dihydrogen dioxide
ESKATA
H2O2
Hioxyl
Hipox
HOOH
Hybrite
Hydrogen dioxide
HYDROGEN PEROXIDE
Hydrogen peroxide (H2O2)
Hydroperoxide
Inhibine
Lase peroxide
|
Lensan a
Magic bleaching
Metrokur
Mirasept
Nite white excel 2
NSC-19892
Odosat D
Opalescence xtra
Oxigenal
Oxydol
Oxyfull
Oxysept
Oxysept I
Pegasyl
Perhydrol
Perone
Peroxaan
Peroxclean
Peroxide, hydrogen
PEROXYL
Quasar brite
Select bleach
Superoxol
T-Stuff
Whiteness HP
Whitespeed
Xtra white
|
|
2 |
|
Bacitracin |
Approved, Vet_approved |
Phase 4 |
|
1405-87-4 |
10909430 |
Synonyms:
A.L. labs brand OF bacitracin zinc salt
Ak tracin
Akorn brand OF bacitracin
Ak-tracin
ALBAC 50
Altracin
Baci im
Baci RX
BACIFERM 50
BACIGUENT
Baci-im
BACIIM
Baci-RX
Bacitin
Bacitracin
Bacitracin a
Bacitracin a2a
Bacitracin akorn brand
Bacitracin dioptic brand
BACITRACIN F, 1-(N-((2-(1-AMINO-2-METHYLBUTYL)-4,5-DIHYDRO-4-THIAZOLYL)CARBONYL)-L-LEUCINE)-
Bacitracin lee brand
Bacitracin mcneil brand
Bacitracin pharmascience brand
|
Bacitracin zinc
Bacitracin zinc complex
Bacitracin, zinc
Bacitracina
Bacitracine martinet
Ciba vision brand OF bacitracin
Dioptic brand OF bacitracin
E700
Lee brand OF bacitracin
Martinet, bacitracine
McNeil brand OF bacitracin
Ocu tracin
Ocumed brand OF bacitracin
Ocu-tracin
OcuTracin
Pharma tek brand OF bacitracin
Pharmascience brand OF bacitracin
Reed and carnrick brand OF bacitracin
Topitracin
Zeba RX
Zeba-RX
Zinc bacitracin
Zinc, bacitracin
|
|
3 |
|
Mineral oil |
Approved, Vet_approved |
Phase 4 |
|
8042-47-5 |
|
Synonyms:
Food Grade Mineral Oil
Heavy Liquid Petrolatum
Heavy mineral oil
Liquid Paraffin
Liquid Petrolatum
Mineral oil
Mineral Oil (high Viscosity)
|
Mineral Oil, Heavy
Paraffin Oil
Paraffin, Liquid
Paraffinum Liquidum
Petrolatum, Liquid
White Mineral Oil
|
|
4 |
|
Prilocaine |
Approved |
Phase 4 |
|
721-50-6 |
4906 |
Synonyms:
2-(Propylamino)-O-propionotoluidide
2-Methyl-alpha-propylaminopropionanilide
2-Methyl-a-propylaminopropionanilide
2-Methyl-α-propylaminopropionanilide
alpha-N-Propylamino-2-methylpropionanilide
a-N-Propylamino-2-methylpropionanilide
ASTRA 1512
Astra 1515
Astra brand OF prilocaine hydrochloride
ASTRA-1512
ASTRA-1515
AstraZeneca brand OF prilocaine hydrochloride
Citanest
Citanest octapressin
Citanest Plain
Delvet brand OF prilocaine hydrochloride
Inibsa brand OF prilocaine hydrochloride
L-67
|
N-(2-Methylphenyl)-2-(propylamino)propanamide
NSC-40027
O-Methyl-2-propylaminopropionanilide
O-Methyl-alpha-propylaminopropionanilide
O-Methyl-a-propylaminopropionanilide
O-Methyl-α-propylaminopropionanilide
Parnell brand OF prilocaine hydrochloride
PRILOCAIN
Prilocaina
PRILOCAINE
PRILOCAÏNE
Prilocaine base
Prilocaine hydrochloride
Prilocainum
PRILOTEKAL
Propitocaine
Xylonest
Α-N-propylamino-2-methylpropionanilide
|
|
5 |
|
Hyaluronic acid |
Approved, Vet_approved |
Phase 4 |
|
9004-61-9 |
53477741 |
Synonyms:
(2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate
(2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
(2S,3S,4R,5R,6R)-3-{[(2S,3R,4R,5S,6R)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5,6-trihydroxyoxane-2-carboxylate
2-Acetamido-2-deoxy-b-D-gluco-hexopyranosyl-(1->4)-b-D-gluco-hexopyranuronate
2-Acetamido-2-deoxy-b-D-gluco-hexopyranosyl-(1->4)-b-D-gluco-hexopyranuronic acid
2-Acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranuronate
|
2-Acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranuronic acid
2-Acetamido-2-deoxy-β-D-gluco-hexopyranosyl-(1->4)-β-D-gluco-hexopyranuronate
2-Acetamido-2-deoxy-β-D-gluco-hexopyranosyl-(1->4)-β-D-gluco-hexopyranuronic acid
Hyaluronan
Hyaluronate
WURCS=2.0/2,2,1/[a2122a-1b_1-5][a2122h-1b_1-5_2*ncc/3=o]/1-2/a4-b1
|
|
6 |
|
Menthol |
Approved, Experimental |
Phase 4 |
|
1490-04-6, 2216-51-5, 15356-60-2 |
1254 16666 165675 |
Synonyms:
(−)-(1R,3R,4S)-menthol
(-)-(1R,3R,4S)-Menthol
(−)-menthol
(-)-Menthol
(-)-Menthyl alcohol
(-)-trans-p-Menthan-cis-ol
(+)-(1S,2R,5S)-menthol
(+)-(1S,3S,4R)-menthol
(+-)-Menthol
(1a,2b,5a)-5-Methyl-2(1-methylethyl)cyclohexanol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1R-(1-a,2-b,5-a))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1R-(1-Α,2-β,5-α))-5-methyl-2-(1-methylethyl)cyclohexanol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-Menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(−)-menthol
(1R,3R,4S)-(-)-Menthol
(1S,2R,5S)-(+)-menthol
(1S,2R,5S)-menthol
(1Α,2β,5α)-5-methyl-2(1-methylethyl)cyclohexanol
(R)-(-)-Menthol
1-Menthol
1-Methyl-4-isopropyl-3-hydroxycyclohexane
2-Isopropyl-5-methylcyclohexanol
3-Hydroxy-P-menthane
3-P-Menthanol
3-P-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-propan-2-ylcyclohexan-1-ol
AQUA-COOL
AQUASOOTHE
ARJUN
CATARRH
|
D-(-)-Menthol
DERMACOOL
DL-menthol
D-menthol
FEMA NO. 2665
Fisherman's friend lozenges
HALLS
Hexahydrothymol
KARVOL
Kerasal
L-(-)-Menthol
Levomenthol
Lévomenthol
Levomentholum
Levomentol
L-Menthol
l-menthol|levomenthol
LOCKETS
MEGGEZONES
Menthacamphor
Menthol
Menthol natural
Menthol racemic
Menthol racemique
Menthol, (1alpha,2beta,5alpha)-isomer
Menthomenthol
Mentol
MUIRS
Peppermint camphor
p-Menthan-3-ol
Racementhol
Racementholum
Racementol
THERAPEUTIC MINERAL ICE
TIXYLIX DECONGESTANT INH
U.S.p. menthol
VOCALZONE
|
|
7 |
|
Tirbanibulin |
Approved, Investigational |
Phase 4 |
|
897016-82-9 |
23635314 |
Synonyms:
Klisyri®|KX 2-391|KX-01|KX-2-391|KX2-391
KX-01
KX2-391
KX-2391
|
KX-2-391
N-Benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide
N-Benzyl-2-(5-{4-[2-(morpholin-4-yl)ethoxy]phenyl}pyridin-2-yl)ethanimidate
TIRBANIBULIN
|
|
8 |
|
Diclofenac |
Approved, Vet_approved |
Phase 4 |
|
15307-86-5, 15307-79-6 |
3033 |
Synonyms:
[2-(2,6-Dichloroanilino)phenyl]acetate
[2-(2,6-Dichloroanilino)phenyl]acetic acid
2-((2,6-Dichlorophenyl)amino)benzeneacetate
2-((2,6-Dichlorophenyl)amino)benzeneacetic acid
2-[(2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
ACOFLAM
ACOFLAM RET
ACOFLAM SR
Allvoran
Apo-Diclo
ARTHRONAC
ARTHROTEC
ARTHROTEC 50
ARTHROTEC 75
Assaren
Benfofen
CAMBIA
CAT458
CATAFLAM
Cataflam®|CGP-45840B|GP-45840|Voltaren®|Voltarol®
CGP-45840B
CLOSTERIL 100
DEFANAC
DEFANAC RETARD
DEFANAC SR
Delphimix
DEXOMON RET
DEXOMON SR
Dichlofenac
Dichlofenal
Dichronic
Diclobenin
Diclofenac
Diclofenac acid
Diclofenac potassium
DICLOFENAC SOD
Diclofenac sodium
DICLOFENAC SODIUM SALT
Diclofenac, sodium
Diclofenaco
Diclofenacum
Diclofenamate
Diclofenamic acid
DICLOFLEX
DICLOFLEX RET
DICLOFLEX SR
DICLOMAX RET
DICLOMAX SR
Diclonate p
Diclophenac
Diclo-Phlogont
Diclo-Puren
Diclord
Dicloreum
DICLOTARD 100 MR
DICLOTARD 75 MR
DICLOVOL
DICLOVOL RET
DICLOVOL SR
DICLOZIP 25
DICLOZIP 50
Dicrofenac
DIFENOR XL
DIGENAC XL 100
Dolobasan
DSG318
Duravolten
DYLOJECT
Ecofenac
ECONAC
ECONAC SR
ECONAC XL
Effekton
ENSTAR SR
ENSTAR XL
ENZED
Feloran
FENACTOL
FENACTOL RET
|
FENACTOL SR
FLAMATAK MR
FLAMRASE
FLAMRASE SR
FLEXOTARD MR
GP-45840
ISCLOFEN
ISV-205
Kriplex
LOFENSAID 25
LOFENSAID 50
LOFENSAID RET 100
LOFENSAID RET 75
MASIDEMEN
MISOFEN
MOBIGEL
MOBIGEL PAINEZE
MOTIFENE
Neriodin
Novapirina
Novo-Difenac
Novo-Difenac SR
Nu-Diclo
Orthofen
Orthophen
Ortofen
PENNSAID
Primofenac
Prophenatin
ProSorb-D
RHEUMATAC RET 75
RHUMALGAN
RHUMALGAN CR 100
RHUMALGAN CR 75
RHUMALGAN SR
RHUMALGAN XL
SLOFENAC
Sodium diclofenac
Solaraze
Solaraze T
SR 38
SR-38
Tsudohmin
VALDIC 100 RET
VALDIC 75 RET
VALENAC
Valetan
VOL458
Voldal
VOLRAMAN
VOLSAID RET 100
VOLSAID RET 75
Voltaren
VOLTAREN EMULGEL
Voltaren Ophtha
VOLTAREN OPHTHALMIC
Voltaren Rapide
VOLTAREN RET
Voltaren SR
VOLTAREN XR
VOLTARENE
VOLTARENE EMULGEL
VOLTARENE L.P.
VOLTARENE RET
VOLTAREN-XR
Voltarol
VOLTAROL 12 HOUR EMULGEL P
VOLTAROL ACTIVE
VOLTAROL EMULGEL
VOLTAROL EMULGEL P
VOLTAROL GEL PATCH
VOLTAROL OPHTHA
VOLTAROL PAIN-EZE EMULGEL
VOLTAROL RET
VOLTAROL SR
Xenid
Zorvolex
ZORVOLEX CAPSULES
|
|
9 |
|
Aminolevulinic acid |
Approved |
Phase 4 |
|
106-60-5 |
137 |
Synonyms:
5 Aminolaevulinate
5 Aminolevulinate
5-ALA
5-Amino-4-oxopentanoate
5-Amino-4-oxo-pentanoate
5-Amino-4-oxopentanoic acid
5-Amino-4-oxo-pentanoic acid
5-Amino-4-oxovalerate
5-Amino-4-oxovaleric acid
5-Aminolaevulinate
5-Aminolaevulinic acid
5-Aminolevulinate
5-Amino-levulinate
5-Aminolevulinic acid
5-Amino-levulinic acid
Acid hydrochloride, aminolevulinic
Acid, aminolevulinic
Acid, Delta-aminolevulinic
|
ácido 5-aminolevulínico
Aladerm
Aminolevulinate
Aminolevulinic acid
Amino-levulinic acid
Aminolevulinic acid hydrochloride
Bertek brand OF aminolevulinic acid hydrochloride
dALA
Delta Aminolevulinic acid
delta-ALA
delta-Aminolevulinate
delta-Aminolevulinic acid
Hydrochloride, aminolevulinic acid
Kerastick
Levulan
δ-ALA
Δ-aminolevulinate
δ-aminolevulinic acid
|
|
10 |
|
Imiquimod |
Approved, Investigational |
Phase 4 |
|
99011-02-6 |
57469 |
Synonyms:
1-Isobutyl-1H-imidazo(4,5-c)quinolin-4-amine
1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline
Aldara
Aldara®|R837|S-26308|Zyclara®
Imiquimod
Imiquimod acetate
|
Imiquimodum
R 837
R-837
S-26308
ZARTRA
Zyclara
|
|
11 |
|
Salicylic acid |
Approved, Investigational, Vet_approved |
Phase 4 |
|
69-72-7 |
338 |
Synonyms:
2 Hydroxybenzoic acid
2-Carboxyphenol
2-Hydroxybenzenecarboxylate
2-Hydroxybenzenecarboxylic acid
2-HYDROXYBENZOate
2-HYDROXYBENZOIC ACID
Acid, 2-hydroxybenzoic
Acid, O-hydroxybenzoic
Acid, ortho-hydroxybenzoic
Acid, salicylic
ácido salicílico
Acidum salicylicum
Advanced pain relief callus removers
Advanced pain relief corn removers
Bazuka Extra Strength Gel®|salicylate
Clear away wart remover
Compound W
Dr. scholl's callus removers
Dr. scholl's corn removers
Dr. scholl's wart remover kit
Duofil wart remover
Duoplant
Freezone
Ionil
|
Ionil plus
K 537
K 557
O Hydroxybenzoic acid
O-Carboxyphenol
O-Hydroxybenzoate
O-Hydroxybenzoic acid
Ortho hydroxybenzoic acid
Ortho-hydroxybenzoic acid
Phenol-2-carboxylate
Phenol-2-carboxylic acid
Psoriacid-S-stift
Retarder W
Rutranex
SA
Salicylate
Salicylic acid
Salicylic acid collodion
Salicylic acid soap
Saligel
Salonil
Stri-dex
trans-Ver-sal
|
|
12 |
|
Vitamin A |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
22737-96-8, 68-26-8 |
5280382 445354 |
Synonyms:
(2E,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)NONA-2,4,6,8-TETRAEN-1-OL
(ALL-E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-2,4,6,8-NONATETRAEN-1-OL
11-CIS-RETINOL
11-cis-Vitamin a alcohol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-e)-isomer
all trans Retinol
all-trans-Retinol
ALL-TRANS-RETINYL ALCOHOL
ALL-TRANS-VITAMIN A ALCOHOL
ALPHALIN
Aquasol a
AROVIT
BETA-RETINOL
B-RETINOL
CHOCOLA A
cis-11-Retinol
|
NEPALM
NSC-122759
OLEOVITAMIN A
Retinol
RETINOL (VIT A)
RETINOL ACETATE
RETINOL PALMITATE
Retinolum
RO-A-VIT
TRANS-RETINOL
Vitamin a
VITAMIN A 1
VITAMIN A OIL
VITAMIN A SOLUBILIZED
Vitamin a1
|
|
13 |
|
Protoporphyrin |
Experimental |
Phase 4 |
|
553-12-8 |
|
Synonyms:
3,3'-(3,7,12,17-Tetramethyl-8,13-divinyl-21H,23H-porphine-2,18-diyl)-bis-propionate
3,3'-(3,7,12,17-Tetramethyl-8,13-divinyl-21H,23H-porphine-2,18-diyl)-bis-propionic acid
3,3'-(3,7,12,17-Tetramethyl-8,13-divinylporphine-2,18-diyl)di
3,7,12,17-Tetramethyl-8,13-divinylporphyrin-2,18-dipropanoate
3,7,12,17-Tetramethyl-8,13-divinylporphyrin-2,18-dipropanoic acid
H2PpIX
Kammerer's prophyrin
|
Ooporphyrin
Porphyrinogen IX
PpIX
Protoporphyrin
Protoporphyrin IX
Protoporphyrin-"ix"
Protoporphyrin-IX
|
|
14 |
|
Radiation-Protective Agents |
|
Phase 4 |
|
|
|
15 |
|
Lidocaine, Prilocaine Drug Combination |
|
Phase 4 |
|
|
|
16 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
17 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
18 |
|
Anti-Infective Agents, Local |
|
Phase 4 |
|
|
|
19 |
|
Protective Agents |
|
Phase 4 |
|
|
|
20 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
21 |
|
Sodium Channel Blockers |
|
Phase 4 |
|
|
|
22 |
|
Anesthetics, Local |
|
Phase 4 |
|
|
|
23 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
24 |
|
Viscosupplements |
|
Phase 4 |
|
|
|
25 |
|
Retinol palmitate |
|
Phase 4 |
|
|
|
26 |
|
Antirheumatic Agents |
|
Phase 4 |
|
|
|
27 |
|
Cyclooxygenase Inhibitors |
|
Phase 4 |
|
|
|
28 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
29 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
30 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
31 |
|
Analgesics |
|
Phase 4 |
|
|
|
32 |
|
Photosensitizing Agents |
|
Phase 4 |
|
|
|
33 |
|
Dermatologic Agents |
|
Phase 4 |
|
|
|
34 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
35 |
|
Methyl 5-aminolevulinate |
|
Phase 4 |
|
|
|
36 |
|
Adjuvants, Immunologic |
|
Phase 4 |
|
|
|
37 |
|
interferons |
|
Phase 4 |
|
|
|
38 |
|
Immunologic Factors |
|
Phase 4 |
|
|
|
39 |
|
Emollients |
|
Phase 4 |
|
|
|
40 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 3 |
|
22916-47-8 |
4189 |
Synonyms:
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
Brentan
CONOFITE
Dactarin
DERMAZOLE
DUMICOAT
Esteve brand OF miconazole
florid(nitrate)|Monistat®|R-14889
Janssen cilag brand OF miconazole
Janssen-cilag brand OF miconazole
Johnston and johnston brand OF miconazole nitrate
LORAMYC
MCZ
MICATIN
|
Miconasil nitrate
Miconazol
Miconazole
Miconazole esteve brand
Miconazole janssen-cilag brand
Miconazole nitrate
Miconazolum
Monistat
MONISTAT-3
MONISTAT-DERM
Nitrate, miconasil
Nitrate, miconazole
NSC-170986
Oravig
VUSION
|
|
41 |
|
Clotrimazole |
Approved, Vet_approved |
Phase 3 |
|
23593-75-1 |
2812 |
Synonyms:
(Chlorotrityl)imidazole
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole
1-(a-(2-Chlorophenyl)benzhydryl)imidazole
1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole
1-(O-Chloro-a,a-diphenylbenzyl)imidazole
1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole
1-(O-Chlorotrityl)imidazole
1-(O-Chloro-α,α-diphenylbenzyl)imidazole
1-(Α-(2-chlorophenyl)benzhydryl)imidazole
ABTRIM
ACTAVALL
Bay b 5097
BAY-5097
Bayer brand 1 OF clotrimazole
Bayer brand 2 OF clotrimazole
CANDIDEN
Canesten
Canesten 1-day cream combi-pak
Canesten 1-day therapy
Canesten 3-day therapy
Canesten 6-day therapy
CANESTEN AF
Canesten combi-pak 1-day therapy
Canesten combi-pak 3-day therapy
Canesten cream
CANESTEN CRM COMBI
CANESTEN INTERNAL
Canesten solution
CANESTEN VC
Canesten®|Lotrimin®
Canestine
Chlotrimazole
Clotrimaderm
Clotrimaderm cream
Clotrimazol
CLOTRIMAZOLE
Clotrimazole schering brand
Clotrimazolum
Desamix F
Empecid
FB b 5097
Fem care
FemCare
FUNGEDERM
GNF-PF-3499
Gyne lotrimin
Gyne-lotrimin
Gyne-lotrimin 3
Gyne-lotrimin 3 combination pack
Gyne-lotrimin combination pack
Gyne-lotrimin3
Gyne-lotrimin3 combination pack
|
Gynix
Kanesten
Klotrimazole
Lopac-C-6019
Lotrimax
Lotrimin
LOTRIMIN (TN)
Lotrimin af
Lotrimin af cream
Lotrimin af jock-itch cream
Lotrimin af lotion
Lotrimin af solution
Lotrimin cream
Lotrimin lotion
Lotrimin solution
Lotrisone
MASNODERM
mono-Baycuten
Monobaycuten
Mycelax
Mycelex
MYCELEX (TN)
Mycelex 7
Mycelex cream
Mycelex g
Mycelex otc
Mycelex solution
Mycelex troches
Mycelex twin pack
Mycelex: mycosporinrimazole
Mycelex-7
Mycelex-7 combination pack
Mycelex-g
MYCIL GOLD
Myclo cream
Myclo solution
Myclo spray solution
Myclo-gyne
Mycosporin
Mykosporin
Neo-zol cream
NSC-257473
Otomax
Pedisafe
Prestwick_120
PRIVACOM
Rimazole
Schering brand OF clotrimazole
Tibatin
Trimysten
Trivagizole 3
Veltrim
|
|
42 |
|
Dimethyl sulfoxide |
Approved, Vet_approved |
Phase 3 |
|
67-68-5 |
679 |
Synonyms:
(CH3)2SO
(Methylsulfinyl)methane
DIMETHYL SULFOXIDE
Dimethyl sulfoxixde
Dimethyl sulfur oxide
Dimethyl sulphoxide
Dimethyl sulphur oxide
Dimethyl sulpoxide
Dimethyli sulfoxidum
Dimethyli sulphoxidum
Dimethylsulfoxid
Dimethylsulfoxide
Dimethylsulfoxyde
Diméthylsulfoxyde
Dimethylsulphinyl
Dimethylsulphoxid
Dimethylsulphoxide
Dimethylsulphoxyde
Dimetil sulfoxido
Dimetil sulfóxido
Dimetil sulphoxido
Dimexide
DMSO
DOMOSO
|
INFILTRINA
Merckle brand OF dimethyl sulfoxide
Methylsulfinylmethane
Methylsulphinylmethane
NSC-763
Research ind. corp. brand 1 OF dimethyl sulfoxide
Research ind. corp. brand 2 OF dimethyl sulfoxide
Rheumabene
Rimso
rimso 100
Rimso 50
Rimso50
Rimso-50
S(O)Me2
Sclerosol
Shire brand OF dimethyl sulfoxide
SQ-9453
Sulfinylbis(methane)
Sulfoxide, dimethyl
Sulphinylbis(methane)
Sulphoxide, dimethyl
SYNTEXAN
Zymso
|
|
43 |
|
Selenium |
Approved, Investigational, Vet_approved |
Phase 3 |
|
7783-07-5, 7782-49-2 |
533 |
Synonyms:
[SeH2]
Dihydrogen monoselenide
Dihydrogen selenide
H2Se
Hydrogen selenide, 75Se-labeled
Hydroselenate
Hydroselenic acid
Se(2+)
Se2+
Selane
Selanediide
Selen
|
Selenide
Selenide(2-)
Selenio
Sélénium
Selenium dication
Selenium dihydride
Selenium elemental
Selenium hydride
Selenium hydride (seh2)
Selenium ion (se2+)
Selenium metallicum
Selenium, elemental
|
|
44 |
|
Selenious acid |
Approved, Investigational |
Phase 3 |
|
14124-67-5, 7783-00-8 |
1091 |
Synonyms:
[seo(OH)2]
Acid, selenious
Acid, selenous
Selenige saeure
|
selenige Säure
Selenious acid
Selenite
Selenous acid
|
|
45 |
|
Fluorouracil |
Approved |
Phase 3 |
|
51-21-8 |
3385 |
Synonyms:
5 Fluorouracil
5 Fluorouracil biosyn
5 FU
5 FU lederle
5 FU medac
5 HU hexal
5.F.U.
5-Fluoracil
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluracil
5FU
5-FU
5-FU lederle
5-FU medac
5-HU hexal
ACCUSITE
ACTIKERALL
Adrucil
Allergan brand OF fluorouracil
Arumel
Biosyn brand OF fluorouracil
Carac
Carzonal
CSP Brand OF fluorouracil
Dakota brand OF fluorouracil
Dakota, fluorouracile
Dermatech brand OF fluorouracil
Dermik brand OF fluorouracil
Effluderm
Efudex
Efudix
Efurix
Ferrer brand OF fluorouracil
Fluoro Uracil
Fluoro uracile icn
Fluoroblastin
Fluoroplex
Fluorouracil
Fluorouracil gry
Fluorouracil mononitrate
Fluorouracil monopotassium salt
Fluorouracil monosodium salt
Fluorouracil potassium salt
FLUORO-URACIL ROCHE
Fluorouracil teva brand
|
Fluorouracile dakota
Fluoro-uracile icn
Fluorouracil-gry
Fluorouracilo
Fluorouracilo ferrer far
Fluorouracilum
Fluoruracil
Fluouracil
Fluracedyl
FLURACIL
Fluracilum
Fluri
Fluril
Fluro Uracil
Flurodex
Flurouracil
Ftoruracil
FU
Gry brand OF fluorouracil
Haemato brand OF fluorouracil
Haemato fu
Haemato-fu
Hexal brand OF fluorouracil
ICN brand OF fluorouracil
Kecimeton
Medac brand OF fluorouracil
Neocorp brand OF fluorouracil
Neofluor
NSC-19893
Onkofluor
Onkoworks brand OF fluorouracil
Pharmachemie brand OF fluorouracil monosodium salt
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Ribosepharm brand OF fluorouracil
Riemser brand OF fluorouracil
RO-29757
RO-2-9757
Roche brand OF fluorouracil
Teva brand OF fluorouracil
Timazin
TOLAK
Ulup
URF
|
|
46 |
|
Keratolytic Agents |
|
Phase 3 |
|
|
|
47 |
|
Antifungal Agents |
|
Phase 3 |
|
|
|
48 |
|
Salicylates |
|
Phase 3 |
|
|
|
Synonyms:
2-Hydroxybenzoate ion(1-)
2-Hydroxybenzoic acid ion(1-)
O-Hydroxybenzoate
|
O-Hydroxybenzoic acid
sal
Salicylic acid
|
|
49 |
|
Trace Elements |
|
Phase 3 |
|
|
|
50 |
|
Micronutrients |
|
Phase 3 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 337)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Topical Ingenol Mebutate Versus 5% 5-fluorouracil Versus 5% Imiquimod Versus Photodynamic Therapy in Treatment of Actinic Keratosis: a Multi-centre Randomized Efficacy and Cost-effectiveness Study |
Unknown status |
NCT02281682 |
Phase 4 |
Imiquimod;5-fluorouracil;Ingenol mebutate |
2 |
Comparative Intraindividual Study, About the Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between Acid Methyl Aminolevulinate Cream and Aminolevulinic Gel |
Unknown status |
NCT02647151 |
Phase 4 |
METHYLAMINOLEVULINATE HYDROCHLORIDE;AMINOLEVULINIC ACID HYDROCHLORIDE |
3 |
A Randomised Double-blind Parallel-group Study to Evaluate the Long-term Effects of Eryfotona AK-NMSC® Cream in the Treatment of Cancerization Field in Patients With Actinic Keratosis. |
Unknown status |
NCT01656226 |
Phase 4 |
|
4 |
An Investigator-Initiated Study to Assess the Safety and Efficacy of Imiquimod 3.75% Cream When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses (AK) on Dorsal Hands and Forearms |
Unknown status |
NCT01229319 |
Phase 4 |
Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm |
5 |
A Double-blind, Randomized, Placebo-controlled, 2-way Crossover Study to Assess the Potential Effect of Topically Applied Imiquimod Cream on Atrial Ectopy in Patients With Actinic Keratosis |
Unknown status |
NCT01413763 |
Phase 4 |
Imiquimod cream 3.75%;Placebo cream |
6 |
An Open-Label Study Assessing Subject Satisfaction With A-101 Hydrogen Peroxide Topical Solution, 40% (w/w) Treatment for Seborrheic Keratoses of the Face, Neck, and Decolletage |
Completed |
NCT03487588 |
Phase 4 |
A-101 Topical Solution |
7 |
A Randomized, Parallel-Group, Vehicle-Controlled, Double-Blind Study of Topical Imiquimod 5% Cream Used as an Adjunct to Cryotherapy in the Management of Actinic Keratoses, With a Long-Term (1 Year) Follow-Up |
Completed |
NCT00110682 |
Phase 4 |
Imiquimod used as an adjunct to cryotherapy |
8 |
Treatment of AKs With Daylight-PDT: Comparing Two Photosensitizers (BF-200 ALA and MAL) |
Completed |
NCT01893203 |
Phase 4 |
BF-200 ALA cream;MAL cream |
9 |
A Randomized Right/Left Clinical Trial to Evaluate the Use of Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy |
Completed |
NCT00695578 |
Phase 4 |
Biafine;Polysporin |
10 |
Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population |
Completed |
NCT00696488 |
Phase 4 |
Fluorouracil 0.5% |
11 |
Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents |
Completed |
NCT03279328 |
Phase 4 |
Topical Steroid Ointment;Skin Barrier Moisturier |
12 |
A Randomized, Open-label, Assessor-blinded, Split-face Study of Imiquimod 5% Cream Applied After Cryotherapy of Actinic Keratoses |
Completed |
NCT00774787 |
Phase 4 |
imiquimod 5% cream |
13 |
An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses |
Completed |
NCT00377273 |
Phase 4 |
fluorouracil cream 0.5% |
14 |
Prospective, Controlled and Monocentric Study to Evaluate the Effects of Topical 3% Diclofenac in 2.5% Hyaluronic Acid Gel on Tumor Metabolism in the Treatment of Actinic Keratoses in Immunocompetent and Immunocompromised Patients |
Completed |
NCT01935531 |
Phase 4 |
3% diclofenac in 2.5% hyaluronic acid gel |
15 |
A Randomized, Evaluator-blinded, Bilateral Comparison of the Treatment of Facial Actinic Keratoses Using Combination Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Different Incubation Times |
Completed |
NCT02622594 |
Phase 4 |
Aminolevulinic Acid (ALA) |
16 |
An Investigator-Initiated Study to Assess the Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses (AK) on Dorsal Hands |
Completed |
NCT02251652 |
Phase 4 |
Ingenol Mebutate |
17 |
A Comparison of the Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Density of Ablative Laser Channel in the Treatment of Actinic Keratosis |
Completed |
NCT03731988 |
Phase 4 |
lidocaine/prilocaine (5%) application;MAL application |
18 |
A Multi-center, OPen, InvEstigator Initiated Phase IV Clinical TRial to Evaluate the Efficacy and SaFety of Ingenol Mebutate Gel 0.015% on Face and Scalp & 0.05% on Trunk and Extremities in KorEan Patient With ACtinic KeraTosis (PERFECT) |
Completed |
NCT02716714 |
Phase 4 |
ingenol mebutate gel 0.015%;ingenol mebutate gel 0.05% |
19 |
Long-term Effects of Aldara® 5% Cream and Solaraze® 3% Gel in the Treatment of Actinic Keratoses on the Face or Scalp (LEIDA) |
Completed |
NCT00777127 |
Phase 4 |
Imiquimod;Diclofenac |
20 |
A Randomized Study to Evaluate the Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization Compared to Cryotherapy |
Completed |
NCT02990221 |
Phase 4 |
Ingenol mebutate |
21 |
Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage |
Completed |
NCT03697590 |
Phase 4 |
No curettage;Curettage |
22 |
Prospective, Randomized, Controlled, Multicenter, Two-armed, Study Comparing Daylight Photodynamic Therapy Using MAL With Cryosurgery for the Treatment and Prophylaxis of Actinic Keratoses in Photodamaged Skin of the Face |
Completed |
NCT02736760 |
Phase 4 |
Daylight photodynamic therapy using Methylaminolevulinate (MAL) |
23 |
A Phase 4 Trial Comparing the Cumulative Incidence of SCC After Treatment With Ingenol Mebutate and Imiquimod for Multiple Actinic Keratoses on Face and Scalp. A Multi-centre, Randomised, Two-arm, Open Label, Active-controlled, Parallel Group, 36-month Trial |
Completed |
NCT01926496 |
Phase 4 |
Ingenol Mebutate Gel, 0.015%;Imiquimod Cream, 5% |
24 |
UCI 14-92 / HS#2015-1889: Phase IV Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses |
Completed |
NCT03327831 |
Phase 4 |
Aminolevulinic Acid |
25 |
A Randomised Double Blind, Placebo Controlled Study of the Efficacy of Topical Menthol for Pain Relief During Topical Photodynamic Therapy |
Completed |
NCT02984072 |
Phase 4 |
Menthol;Aqueous Cream |
26 |
Open-Label Safety and Pharmacokinetic Study of AldaraTM (Imiquimod) Cream, 5% for One, Two, or Three Treatment Cycles to Surface Areas Greater Than 25 cm2 With Actinic Keratosis |
Completed |
NCT00116649 |
Phase 4 |
imiquimod cream |
27 |
Vehicle-Controlled, Double-Blind Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Upper Extremities |
Completed |
NCT00115154 |
Phase 4 |
Aldara (imiquimod) cream, 5% |
28 |
Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® PDT |
Completed |
NCT01000636 |
Phase 4 |
|
29 |
Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial |
Completed |
NCT04875026 |
Phase 4 |
5-fluorouracil 4% (Tolak) |
30 |
Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp |
Completed |
NCT02406014 |
Phase 4 |
Ingenol Mebutate Gel, 0.015%;Diclofenac sodium gel 3% |
31 |
Daylight Mediated Photodynamic Therapy for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL) |
Completed |
NCT02464709 |
Phase 4 |
Aminolevulinic Acid;Methyl 5-aminolevulinate |
32 |
Clinical and Dermoscopic Evaluation of Long-pulsed 1064 nm Nd-YAG Laser Versus Trichloroacetic Acid 20% in Treatment of Keratosis Pilaris |
Completed |
NCT04797663 |
Phase 4 |
TCA 20% |
33 |
Comparison of the Efficacy and Tolerability of Solaraze for 3 vs. 6 Months in Patients With Mild to Moderate Actinic Keratosis Located at the Face and Head |
Completed |
NCT00204542 |
Phase 4 |
Diclofenac |
34 |
Subject Reported Outcomes on Satisfaction, Safety and Efficacy With Luxerm® in the Field-directed Treatment of Thin or Non-hyperkeratotic and Non-pigmented Actinic Keratosis of the Face or the Scalp |
Completed |
NCT03511326 |
Phase 4 |
Methyl Aminolaevulinate 16% Cream |
35 |
A Pilot Prospective Clinical Trial to Evaluate the Efficacy and Safety of Large-Scale, Field-Directed Topical Therapy of Actinic Keratosis of the Chest With Ingenol Mebutate 0.015% |
Completed |
NCT02446223 |
Phase 4 |
Inggenol Mebutate 0.015% |
36 |
Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream |
Completed |
NCT04842422 |
Phase 4 |
Imiquimod 3.75% Cream |
37 |
Long-term Effects of Aldara® 5% Cream and Solaraze® 3% Gel in the Treatment of Actinic Keratoses on the Face or Scalp With Respect to the Risk of Progression to In-situ and Invasive Squamous Cell Carcinoma |
Completed |
NCT01453179 |
Phase 4 |
Imiquimod;Diclofenac |
38 |
Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of Actinic Keratosis on the Face in Solid Organ Transplant Recipients |
Completed |
NCT02866695 |
Phase 4 |
ingenol mebutate gel 0.015% |
39 |
Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention: A Long-term (3 Years) Follow-up of Prospective, Randomized, Multicenter-clinical Trial |
Recruiting |
NCT03642535 |
Phase 4 |
ALA |
40 |
A Phase 4, Multi-centre, Randomized, Evaluator-blinded, Active-controlled Study to Determine the Incidence of Squamous Cell Carcinoma and Evaluate the Long-term Safety of Tirbanibulin 10 mg/g Ointment and Diclofenac Sodium 3% Gel for the Treatment of Adult Patients With Actinic Keratosis on the Face or Scalp |
Recruiting |
NCT05387525 |
Phase 4 |
Tirbanibulin (Klisyri®) 10 mg/g ointment;Diclofenac Sodium 3% Gel |
41 |
Safety and Efficacy of Photodynamic Therapy With Aminolevulinic Acid 10% Topical Gel Activated by Red Light Versus Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for the Treatment of Actinic Keratosis on the Upper Extremities: A Blinded Randomized Study |
Not yet recruiting |
NCT05359419 |
Phase 4 |
|
42 |
A Study to Investigate the Effect of Different Durations of Ameluz Application on Response to Treatment of Acral Actinic Keratoses |
Suspended |
NCT03963102 |
Phase 4 |
Ameluz |
43 |
Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study |
Terminated |
NCT00944216 |
Phase 4 |
Salkera Emollient Foam |
44 |
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy |
Terminated |
NCT01203878 |
Phase 4 |
Photodynamic therapy;Imiquimod |
45 |
Topical Imiquimod 5% Cream Therapy Versus Photodynamic Therapy With Methyl-aminolaevulinate 16% Cream of Actinic Keratoses in Organ Transplant Recipients |
Terminated |
NCT01538901 |
Phase 4 |
imiquimod 5% cream |
46 |
A RANDOMIZED, DOUBLE BLIND, MULTI-CENTER CLINICAL STUDY TO TEST THE SAFETY AND EFFICACY OF T4N5 LIPOSOME LOTION ON PATIENTS WITH XERODERMA PIGMENTOSUM IN THE PROTECTION AGAINST ACTINIC KERATOSES |
Unknown status |
NCT00002811 |
Phase 3 |
liposomal T4N5 lotion |
47 |
Phase III Comparative Study About the Use of 5% 5-fluorouracil Cream Versus Its Utilization as Agent for Sequential Superficial Peeling in the Treatment of Advanced Photoaging |
Unknown status |
NCT01405144 |
Phase 3 |
5-fluoruracil |
48 |
An Open-Label Study of the Safety of A-101 Solution 40% in Subjects With Seborrheic Keratosis on the Trunk, Extremities and Face. |
Completed |
NCT02667288 |
Phase 3 |
A-101 Solution |
49 |
A Randomized, Double-Blind, Vehicle-Controlled, PArallel Group Study of the Safety and Effectiveness of A-101 Solution 40% in Subjects With Seborrheic Keratosis on the Trunk, Extremities and Face. |
Completed |
NCT02667275 |
Phase 3 |
A-101 Solution |
50 |
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Safety and Effectiveness of A-101 Solution 40% in Subjects With Seborrheic Keratosis on the Trunk, Extremities and Face. |
Completed |
NCT02667236 |
Phase 3 |
A-101 Solution |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Diclofenac
Diclofenac Potassium
Diclofenac Sodium
|
Fluorouracil
Masoprocol
|
Cochrane evidence based reviews: keratosis
|